316 related articles for article (PubMed ID: 31584593)
1. Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.
Li Q; Yu Q; Ji J; Wang P; Li D
Mol Omics; 2019 Dec; 15(6):406-419. PubMed ID: 31584593
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
3. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma.
Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S
J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network.
Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X
Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531
[TBL] [Abstract][Full Text] [Related]
5. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
6. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
[TBL] [Abstract][Full Text] [Related]
7. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
Wang H; Liu D; Yang J
Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of lncRNA-TF crosstalks and identification of prognostic regulatory feedback loops of glioblastoma using lncRNA/TF-mediated ceRNA network.
Ji Y; Gu Y; Hong S; Yu B; Zhang JH; Liu JN
J Cell Biochem; 2020 Jan; 121(1):755-767. PubMed ID: 31478223
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
10. Sequencing and Bioinformatics analysis of lncRNA/circRNA-miRNA-mRNA in Glioblastoma multiforme.
Wang R; Li Q; Chu X; Li N; Liang H; He F
Metab Brain Dis; 2023 Oct; 38(7):2289-2300. PubMed ID: 37389689
[TBL] [Abstract][Full Text] [Related]
11. LncRNA and mRNA expression profiles of glioblastoma multiforme (GBM) reveal the potential roles of lncRNAs in GBM pathogenesis.
Li Q; Jia H; Li H; Dong C; Wang Y; Zou Z
Tumour Biol; 2016 Nov; 37(11):14537-14552. PubMed ID: 27604987
[TBL] [Abstract][Full Text] [Related]
12. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
13. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma.
Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G
Front Immunol; 2021; 12():706936. PubMed ID: 34899682
[TBL] [Abstract][Full Text] [Related]
14. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
[TBL] [Abstract][Full Text] [Related]
16. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
Li M; Long S; Hu J; Wang Z; Geng C; Ou S
Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
[TBL] [Abstract][Full Text] [Related]
17. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
18. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms.
Ding Y; Li T; Yan X; Cui M; Wang C; Wang S; Zhang F; Zhang R
Mol Genet Genomics; 2021 Mar; 296(2):423-435. PubMed ID: 33507382
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]